Biblio

Author Title Type [ Year

]

Filters: First Letter Of Title is C [Clear All Filters]

2024

Masadah R, Ikram D, Riadi R, Tangdiung Y, Nelwan BJulian, Ghaznawie M, Rauf S, Faruk M. CD133, CD47, and PD-L1 Expression in Ovarian High-grade Serous Carcinoma and Its Association with Metastatic Disease: A Cross-sectional Study. Asian Pac J Cancer Prev. 2024;25(1):249-255.

Sato T, Oshi M, Huang JLi, Chida K, Roy AMariam, Endo I, Takabe K. CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer. Res Sq. 2024.

Kharouf N, Flanagan TW, AlAmodi AA, Hmada YAl, Hassan S-Y, Shalaby H, Santourlidis S, Hassan S-L, Haikel Y, Megahed M, et al. CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance. Cells. 2024;13(3).

Sharma A, Somasundaram I, Chabaud MBlot. CD146 as a prognostic marker in breast cancer: A meta-analysis. J Cancer Res Ther. 2024;20(1):193-198.

Kong D, Kwon D, Moon B, Kim D-H, Kim M-J, Choi J, Kang K-S. CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment. Biomed Pharmacother. 2024;174:116436.

Fischbach F, Richter J, Pfeffer LKristina, Fehse B, Berger SCarolina, Reinhardt S, Kuhle J, Badbaran A, Rathje K, Gagelmann N, et al. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med. 2024.

Li H, Miao Y-Q, Suo L-P, Wang X, Mao Y-Q, Zhang X-H, Zhou N, Tian J-R, Yu X-Y, Wang T-X, et al. CD206 modulates the role of M2 macrophages in the origin of metastatic tumors. J Cancer. 2024;15(5):1462-1486.

Jang Y, Kang S, Han HHo, Kim BGil, Cho NHoon. CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation. Cell Death Discov. 2024;10(1):81.

Buldini B, Varotto E, Maurer-Granofszky M, Gaipa G, Schumich A, Brüggemann M, Mejstrikova E, Cazzaniga G, Hrusak O, Szczepanowski M, et al. CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment. Blood. 2024.

Ibneeva L, Singh SPal, Sinha A, Eski SElif, Wehner R, Rupp L, Kovtun I, Pérez-Valencia JAlberto, Gerbaulet A, Reinhardt S, et al. CD38 promotes hematopoietic stem cell dormancy. PLoS Biol. 2024;22(2):e3002517.

Murtadha M, Park M, Zhu Y, Caserta E, Napolitano O, Tandoh T, Moloudizargari M, Pozhitkov A, Singer MK, Dona AAlice, et al. CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNγ-induced CD38 expression. Blood. 2024.

Avery D, Morandini L, Sheakley L, Grabiec M, Olivares-Navarrete R. CD4 and CD8 T Cells Reduce Inflammation and Promote Bone Healing in Response to Titanium Implants. Acta Biomater. 2024.

Dwina Y, Zaid LSeptina Ma, Saraswati M, Rachmadi L, Kekalih A, Rahadiani N, Louisa M, Agustina H, Mochtar CArif, Hamid ARizal Ardy. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer. Prostate. 2024.

Seeneevassen L, Zaafour A, Varon C. CD44-Based Detection of CSCs: CD44 Immunodetection by Flow Cytometry. Methods Mol Biol. 2024;2777:71-81.

Zhang S, Li J, Li C, Xie X, He J, Ling F, Li B, Wu H, Li Z, Zhen J, et al. CD73-positive pediatric urethral mesenchymal stem-like cell-derived small extracellular vesicles stimulate angiogenesis. Regen Ther. 2024;25:77-84.

Bai Y, Sun X, Li M, Niu X, Cao W, Niu J, Xiao X, Chen Y, Sun K. CD7-positive leukemic blasts with mutations predict poor prognosis in patients with acute myeloid leukemia. Front Oncol. 2024;14:1342998.

Wang J, Xi Y-F, Zhao Q, Guo J-H, Zhang Z, Zhang M-B, Chang J, Wu Y-Q, Su W. CDKN2A promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine. Mol Biol Rep. 2024;51(1):385.

Sun J, Sepulveda JL, Komissarova EV, Hills C, Seckar TD, LeFevre NM, Simonyan H, Young C, Su G, Del Portillo A, et al. CDKN2A-p16 deletion and activated KRAS drive Barrett's-like gland hyperplasia-metaplasia and synergize in the development of dysplasia pre-cancer lesions. Cell Mol Gastroenterol Hepatol. 2024.

Bulger EA, McDevitt TC, Bruneau BG. CDX2 dose-dependently influences the gene regulatory network underlying human extraembryonic mesoderm development. Biol Open. 2024.

Du M, Wang M, Liu M, Fu S, Lin Y, Huo Y, Yu J, Yu X, Wang C, Xiao H, et al. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription. J Exp Clin Cancer Res. 2024;43(1):79.

Herrera F, Torres D, Laborde A, Jordán R, Mañez N, Berruezo L, Lambert S, Suchowiercha N, Costantini P, Nenna A, et al. Ceftazidime-Avibactam Improves Outcomes in High-Risk Neutropenic Patients with Carbapenemase-Producing Enterobacterales Bacteremia. Microorganisms. 2024;12(1).

Melnikov NP, Lavrov AI. Cell cycle dynamics of food-entrapping cells of sponges: an experimental approach. FEBS J. 2024.

Tur S, Palii CG, Brand M. Cell fate decision in erythropoiesis: insights from multi-omics studies. Exp Hematol. 2024:104167.

Wang J, Zhang B, Chen X, Xin Y, Li K, Zhang C, Tang K, Tan Y. Cell mechanics regulate the migration and invasion of hepatocellular carcinoma cells via JNK signaling. Acta Biomater. 2024.

Kulatunge DR, K Jayawardana H, Abeysekera AM, S Wijeyaratne C, Gunaherath GMKamal B. cell migration enhancing constituents from , a plant used in the preparation of 'Pinda oil', a medicinal oil used in Ayurveda for wound management. Nat Prod Res. 2024:1-7.

Pages